These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6290059)

  • 1. Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
    Havemann K
    Cancer Treat Rev; 1982 Jun; 9 Suppl():95-100. PubMed ID: 6290059
    [No Abstract]   [Full Text] [Related]  

  • 2. [3 multicenter phase II studies of the treatment of small cell bronchogenic carcinoma (incl. AIO studies BI + BII)].
    Liesenfeld A; Havemann K; Gropp C; Seifert W; Thomas C; Drings P; Mahnke HG; Westerhausen M; Wellens W; Konrad RM
    Onkologie; 1984 Jun; 7(3):145-51. PubMed ID: 6087231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide after ACO treatment for small-cell bronchogenic carcinoma.
    Essers U; Knechten H; Seelis R; Ammon J
    Cancer Treat Rev; 1982 Jun; 9 Suppl():111-3. PubMed ID: 6290054
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
    Drings P; Manke HG
    Strahlentherapie; 1985 Mar; 161(3):131-3. PubMed ID: 2983459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoposide as single agent and in combination chemotherapy of bronchogenic carcinoma.
    Goldhirsch A; Joss R; Cavalli F; Brunner KW
    Cancer Treat Rev; 1982 Jun; 9 Suppl():85-90. PubMed ID: 6290057
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.
    Klastersky J; Sculier JP; Nicaise C; Weerts D; Mairesse M; Libert P; Rocmans P; Michel J; Ferremans W
    Cancer Treat Rep; 1983; 67(7-8):727-30. PubMed ID: 6347374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of metastatic non-small cell bronchogenic carcinoma.
    Hoffman PC; Bitran JD; Golomb HM
    Semin Oncol; 1983 Mar; 10(1):111-22. PubMed ID: 6301062
    [No Abstract]   [Full Text] [Related]  

  • 8. Small-cell bronchogenic carcinoma--primary and relapse therapy with etoposide (VP-16), methotrexate and CCNU.
    Niederle N; Krischke W; Bremer K; Schmidt CG; Seeber S
    Cancer Treat Rev; 1982 Jun; 9 Suppl():101-5. PubMed ID: 6290053
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide and cis-platinum in non-small-cell bronchogenic carcinoma.
    Klastersky J; Longeval E; Nicaise C; Weerts D
    Cancer Treat Rev; 1982 Jun; 9 Suppl():133-8. PubMed ID: 6889918
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
    Cohen MH; Ihde DC; Bunn PA; Fossieck BE; Matthews MJ; Shackney SE; Johnston-Early A; Makuch R; Minna JD
    Cancer Treat Rep; 1979 Feb; 63(2):163-70. PubMed ID: 221114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential chemotherapy in good-prognosis patients with small-cell lung cancer.
    Twelves CJ; Goldman J; Ash CM; Souhami RL; Harper PG; Spiro SG; Geddes D; Tobias JS
    Cancer Chemother Pharmacol; 1991; 28(2):139-41. PubMed ID: 1647892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of inoperable non-small-cell bronchogenic carcinoma with etoposide and cis-platinum.
    Mitrou PS; Fischer M; Weissenfels I; Diehl V; Gropp C; Liesenfeld A; Schmidt M; Berdel WE; Fink U; Graubner M
    Cancer Treat Rev; 1982 Jun; 9 Suppl():139-42. PubMed ID: 6889919
    [No Abstract]   [Full Text] [Related]  

  • 14. Two randomized trials for alternating polychemotherapy of small cell lung cancer.
    Havemann K; Gropp C; Klapsing J; Viktor N; Holle R; Drings P; Manke HG; Hans K; Schroeder M; Heim M
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S40-4. PubMed ID: 3028663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide alone and in combination with cyclophosphamide, adriamycin and cis-platinum in patients with Mo and Mi non-small-cell lung cancer.
    Eagan RT
    Cancer Treat Rev; 1982 Jun; 9 Suppl():119-31. PubMed ID: 6889917
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
    Cohen MH; Broder LE; Fossieck BE; Ihde DC; Minna JD
    Cancer Treat Rep; 1977; 61(3):489-90. PubMed ID: 194694
    [No Abstract]   [Full Text] [Related]  

  • 17. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma.
    Osterlind K; Dombernowsky P; Sørensen PG; Hansen HH
    Cancer Treat Rep; 1981; 65(3-4):245-8. PubMed ID: 6263469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
    Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
    J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ifosfamide and adriamycin after induction with cisplatin and etoposide (VP-16) in pulmonary microcytoma. Preliminary results].
    Antilli A; Cruciani AR; Nunziati F; Orazi D; Portalone L; Signora M; Salvati F
    G Ital Chemioter; 1985; 32(1):71-2. PubMed ID: 3007254
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-dose etoposide in combination with vincristine and doxorubicin in the treatment of small-cell lung cancer (SCLC).
    Timothy AR; Calman FM; Bateman NT; Farebrother M; Slevin ML; Bellamy D; Rubens RD; Costello J
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):45-7. PubMed ID: 2983435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.